Patent · US Active

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid

US11707507B2 · kind B2 · utility

0Cited by
5References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2019
Grant dateJul 25, 2023
Priority date
Expiry dateOct 10, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An injectable aqueous solution, of which the pH is from 6.0 to 8.0, comprising at least: a) amylin, an amylin receptor agonist or an amylin analog; b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, said co-polyamino acid consisting of glutamic or aspartic units and said hydrophobic radicals Hy having the following formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.